Advanced Life Sciences Holdings, Inc. (NASDAQ: ADLS)

Advanced Life Sciences Holdings, Inc. (NASDAQ: ADLS), a biopharmaceutical company, is focused discovering, developing, and commercializing novel drugs in the therapeutic areas of respiratory diseases, infection, and cancer. Cethromycin, the Company’s lead candidate, is a novel NDA-stage once-a-day oral antibiotic designed to treat respiratory tract infections, such as pneumonia. For further information, visit the Company’s web site at www.advancedlifesciences.com.